Deciphering the Arginine-Binding Preferences at the Substrate-Binding Groove of Ser/Thr Kinases by Computational Surface Mapping
暂无分享,去创建一个
[1] N. Gray,et al. Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.
[2] A. Toker. Signaling through protein kinase C. , 1998, Frontiers in bioscience : a journal and virtual library.
[3] E. Krebs,et al. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. , 1977, The Journal of biological chemistry.
[4] D. Alessi,et al. The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.
[5] Susan S. Taylor,et al. Protein kinases: evolution of dynamic regulatory proteins. , 2011, Trends in biochemical sciences.
[6] D. Tobi,et al. Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification* , 2004, Journal of Biological Chemistry.
[7] Yu Xue,et al. A summary of computational resources for protein phosphorylation. , 2010, Current protein & peptide science.
[8] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[9] M Pastor,et al. A novel strategy for improving ligand selectivity in receptor-based drug design. , 1995, Journal of medicinal chemistry.
[10] E. Krebs,et al. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. , 1991, The Journal of biological chemistry.
[11] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[12] Johann Hofmann,et al. The potential for isoenzyme‐selective modulation of protein kinase C , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] P. Jennings,et al. Coupling phosphoryl transfer and substrate interactions in protein kinases. , 2005, Biochimica et biophysica acta.
[14] J. Herrero,et al. Kinase peptide specificity: improved determination and relevance to protein phosphorylation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[16] A. Levitzki,et al. Novel method for the synthesis of urea backbone cyclic peptides using new Alloc‐protected glycine building units , 2010, Journal of peptide science : an official publication of the European Peptide Society.
[17] M. Niv,et al. Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor. , 2008, Journal of combinatorial chemistry.
[18] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[19] Susan S. Taylor,et al. cAMP‐dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransfer , 1994, Protein science : a publication of the Protein Society.
[20] Alan E. Mark,et al. The GROMOS96 Manual and User Guide , 1996 .
[21] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Bruce Stillman,et al. Deciphering Protein Kinase Specificity through Large-scale Analysis of Materials Supplemental Deciphering Protein Kinase Specificity through Large-scale Analysis of Yeast Phosphorylation Site Motifs , 2010 .
[23] M. Eisenstein,et al. Peptide inhibitors targeting protein kinases. , 2009, Current pharmaceutical design.
[24] Eugene I Shakhnovich,et al. Amino acids determining enzyme-substrate specificity in prokaryotic and eukaryotic protein kinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] Dima Kozakov,et al. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..
[26] R. Espinosa,et al. Cloning and Characterization of MST4, a Novel Ste20-like Kinase* , 2001, The Journal of Biological Chemistry.
[27] M. Khrestchatisky,et al. Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.
[28] R. Pearson,et al. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. , 1991, Methods in enzymology.
[29] D. Fairlie,et al. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. , 2007, Drug discovery today.
[30] Zhou Songyang,et al. Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.
[31] Susan S. Taylor,et al. Synergistic Binding of Nucleotides and Inhibitors to cAMP-dependent Protein Kinase Examined by Acrylodan Fluorescence Spectroscopy* , 1997, The Journal of Biological Chemistry.
[32] Bostjan Kobe,et al. Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites , 2008, BMC Bioinformatics.
[33] Stefan Knapp,et al. Structure and Substrate Specificity of the Pim-1 Kinase* , 2005, Journal of Biological Chemistry.
[34] S. Taylor,et al. Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Fabbro,et al. Structural biology contributions to tyrosine kinase drug discovery. , 2009, Current opinion in cell biology.
[36] Debasisa Mohanty,et al. Identification of substrates for Ser/Thr kinases using residue-based statistical pair potentials , 2010, Bioinform..
[37] Joost Schymkowitz,et al. Computational design of peptide ligands. , 2011, Trends in biotechnology.
[38] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[39] Adrian L Gill,et al. A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. , 2007, Current topics in medicinal chemistry.
[40] Yanli Wang,et al. Multiple intermolecular interaction modes of positively charged residues with adenine in ATP-binding proteins. , 2003, Journal of the American Chemical Society.
[41] P. Cohen. Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.
[42] Eduardo Garcia Urdiales,et al. Accurate Prediction of Peptide Binding Sites on Protein Surfaces , 2009, PLoS Comput. Biol..
[43] Paramjit S. Arora,et al. An Orthosteric Inhibitor of the Ras-Sos Interaction , 2011, Nature chemical biology.
[44] R. Vaillancourt,et al. MAP3Ks as central regulators of cell fate during development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.
[45] Stephen Shaw,et al. A Single Pair of Acidic Residues in the Kinase Major Groove Mediates Strong Substrate Preference for P-2 or P-5 Arginine in the AGC, CAMK, and STE Kinase Families* , 2005, Journal of Biological Chemistry.
[46] J. Zheng,et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[47] Harel Weinstein,et al. A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains. , 2005, Journal of the American Chemical Society.
[48] Tamotsu Noguchi,et al. PDB-REPRDB: a database of representative protein chains from the Protein Data Bank (PDB) in 2003 , 2003, Nucleic Acids Res..
[49] Susan S. Taylor,et al. 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. , 1993, Acta crystallographica. Section D, Biological crystallography.
[50] M. Niv,et al. Prevention of insulin resistance and beta‐cell loss by abrogating PKCε‐induced serine phosphorylation of muscle IRS‐1 in Psammomys obesus , 2008, Diabetes/metabolism research and reviews.
[51] L. Johnson,et al. The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition , 1997, The EMBO journal.
[52] H. Matter,et al. Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. , 2002, Journal of medicinal chemistry.
[53] Brian A. Hemmings,et al. Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP , 2002, Nature Structural Biology.
[54] Hua Tang,et al. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. , 2011, ACS chemical biology.
[55] L. Pinna,et al. How do protein kinases recognize their substrates? , 1996, Biochimica et biophysica acta.
[56] M. Grdiša. The delivery of biologically active (therapeutic) peptides and proteins into cells. , 2011, Current Medicinal Chemistry.
[57] Emiko Fire,et al. The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer , 2010, Nature chemical biology.
[58] Roderick E Hubbard,et al. Informatics and modeling challenges in fragment-based drug discovery. , 2007, Current opinion in drug discovery & development.
[59] Mindy I. Davis,et al. A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.
[60] S. Knapp,et al. Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites* , 2007, Journal of Biological Chemistry.
[61] Woody Sherman,et al. Computational approaches for fragment-based and de novo design. , 2010, Current topics in medicinal chemistry.
[62] Alexander D. MacKerell,et al. Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..
[63] Philip R. Cohen,et al. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase‐1 identifies a relatively specific substrate for p70 S6 kinase: the N‐terminal kinase domain of MAPKAP kinase‐1 is essential for peptide phosphorylation , 1995, FEBS letters.
[64] M. Niv,et al. BlockMaster: partitioning protein kinase structures using normal-mode analysis. , 2009, The journal of physical chemistry. A.
[65] N. Xuong,et al. A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. , 1997, Structure.
[66] M. Eisenstein,et al. Computational mapping of anchoring spots on protein surfaces. , 2010, Journal of molecular biology.
[67] M. Yaffe,et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways , 2001, Nature Biotechnology.
[68] Bostjan Kobe,et al. The Predikin webserver: improved prediction of protein kinase peptide specificity using structural information , 2008, Nucleic Acids Res..
[69] T. Hunter,et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.
[70] M. Verdonk,et al. A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. , 2007, Current topics in medicinal chemistry.
[71] J. Audie,et al. The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: the time is right. , 2010, Current pharmaceutical design.
[72] Masha Y Niv,et al. Peptidic modulators of protein‐protein interactions: Progress and challenges in computational design , 2009, Biopolymers.
[73] P. Cohen,et al. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.
[74] Toshiyuki Obata,et al. Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKB* , 2000, The Journal of Biological Chemistry.
[75] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[76] Avraham Ben-Shimon,et al. Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt). , 2011, Journal of medicinal chemistry.
[77] E. Krebs,et al. Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[78] S. Knapp,et al. Structural and Functional Characterization of the Human Protein Kinase ASK1 , 2007, Structure.
[79] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[80] Zhou Songyang,et al. Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes* , 1997, The Journal of Biological Chemistry.
[81] J. Ferrell,et al. Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.
[82] Ioannis Xenarios,et al. T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension , 2011, Nucleic Acids Res..
[83] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[84] J. Herrero,et al. Exceptional Disfavor for Proline at the P+1 Position among AGC and CAMK Kinases Establishes Reciprocal Specificity between Them and the Proline-directed Kinases* , 2005, Journal of Biological Chemistry.
[85] B. Werneburg,et al. Pim kinase substrate identification and specificity. , 2006, Journal of biochemistry.
[86] T. Soderling. Structure and regulation of calcium/calmodulin-dependent protein kinases II and IV. , 1996, Biochimica et biophysica acta.
[87] D. Knighton,et al. 2.0 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent. , 1993, Acta crystallographica. Section D, Biological crystallography.
[88] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.